Influence of lactoferrin in preventing preterm delivery: A pilot study

Molecular Medicine Reports

Volumn 5, Issue 1, 2012, Pages 162-166

  Giunta, Giuliana ^a   Giuffrida, Lorena ^a   Mangano, Katia ^b   Fagone, Paolo ^b   Cianci, Antonio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

IL 6; Lactoferrin; Preterm delivery

Indexed keywords

ATOSIBAN; FERROUS SULFATE; INTERLEUKIN 6; LACTOFERRIN; LATTOFERRINA; RECOMBINANT HUMAN LACTOFERRIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CERVICAL LENGTH MEASUREMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; IRON DEFICIENCY ANEMIA; PREMATURE LABOR; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVICITIS; UTERINE CERVIX RIPENING; VAGINA DISCHARGE; VAGINITIS;

ADMINISTRATION, ORAL; ADULT; ANEMIA, IRON-DEFICIENCY; ANTI-INFECTIVE AGENTS; CERVIX MUCUS; FEMALE; FERROUS COMPOUNDS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INTERLEUKIN-6; LACTOFERRIN; PILOT PROJECTS; PREGNANCY; PREMATURE BIRTH; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; VAGINA; VAGINAL SMEARS; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 84855252118     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.584     Document Type: Article

References (32)

1. Randis TM: Progress toward understanding of infection-related preterm birth. Clin Perinatol 37: 677-688, 2010.
2. Donders GG: Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol 21: 355-373, 2007.
3. Chiu YC, Lin CY, Chen CP, et al.: Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1 dependent pathway. J Immunol 183: 2785-2792, 2009.
4. Elass E, Masson M, Mazurier J and Legrand D: Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycanbinding ability of interleukin-8 in human endothelial cells. Infect Immun 70: 1860-1866, 2002. (Pubitemid 34245400)
5. Liggins GC: Cervical ripening as an inflammatory reaction. In: The cervix in Pregnancy and Labor. Ellwood DA, Anderson ABM (eds). Churchill-Livingstone, Edinburgh, pp1-9, 1983.
6. Winkler M: Role of cytokines and other inflammatory mediators. Br J Obstet Gynecol 110 (Suppl 20): 118-123, 2003.
7. Sakai M, Sasaki Y, Yoneda S, et al.: Elevated interleukin-8 in cervical mucus as an indicator for treatment to prevent premature birth and preterm, pre-labor rupture of membranes: a prospective study. Am J Reprod Immunol 51: 220-225, 2004. (Pubitemid 38443580)
8. Keelan JA, Blumenstein M, Helliwell RJ, et al.: Cytokines, prostaglandins, and parturitionda review. Placenta 24 (Suppl A): S33-S46, 2003.
9. Rodríguez-Franco DA, Vázquez-Moreno L and Ramos-Clamont Montfort G: Antimicrobial mechanisms and potential clinical application of lactoferrin. Rev Latinoam Microbiol 47: 102-111, 2005.
10. Arnold RR, Brewer M and Gauthier JJ: Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun 28: 893-898, 1980. (Pubitemid 10122520)
11. Staut J, Norrell S and Harrington JP: Kinetic effect of human lactoferrin on growth of Escherichia coli O-111. Int J Biochem 16: 1043-1047, 1984. (Pubitemid 15175907)
12. Ellison RT III, Giehl TJ and LaForce FM: Damage of outer membrane of the enteric Gram-negative bacteria by lactoferrin and transferring. Infect Immun 56: 2774-2781, 1988. (Pubitemid 18259927)
13. Paesano R, Pietropaoli M, Gessani S and Valenti P: The influence of lactoferrin, orally admnistered, on systemic iron homeostasis in pregnant women suffering of iron deficiency and iron deficiency anemia. Biochimie 91: 44-51, 2009.
14. Paesano R and Torcia F, Berlutti F, et al.: Oral administration of lactoferrin increases hemoglobin and total serum iron in pregnant women. Biochem Cell Biol 84: 377-380, 2006. (Pubitemid 44341314)
15. Bothwell H: Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 72: S257-S264, 2000.
16. Yakuwa K and Otsuki K: Recombinanat human lactoferrin has a potential to suppress uterine cervical ripening in preterm delivery in animal model. Arch Gynecol Obtet 275: 331-334, 2007. (Pubitemid 46466370)
17. Wei SQ, Fraser W and Luo ZC: Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol 116 (2 Pt 1): 393-401, 2010.
18. Kemp MW, Saito M, Newnham JP, et al.: Preterm birth, infection, and inflammation advances from the study of animal models. Reprod Sci 17: 619-628, 2010.
19. Lange M, Chen FK, Wessel J, Buscher U and Dudenhausen JW: Elevation of interleukin-6 levels in cervical secretions as a predictor of preterm delivery. Acta Obstet Gynecol Scand 82: 326-329, 2003. (Pubitemid 36570715)
20. Romero R, Yoon BH, Mazor M, et al.: The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and Gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 169: 805-816, 1993. (Pubitemid 23317510)
21. Mitsuhiro F, Masashi M, Tanamoto K, Suzuki T, Azuma H and Ikeda H: Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100: 171-194, 2003. (Pubitemid 37377912)
22. Dudley DJ: Pre-term labor: an intra-uterine inflammatory response syndrome? J Reprod Immunol 36: 93-109, 1997.
23. Yoon BH, Park CW and Chaiworapongsa T: Intrauterine infection and the development of cerebral palsy. Br J Obstet Gynecol 20 (Suppl 110): 124-127, 2003. (Pubitemid 36577401)
24. Soukka T, Tenovuo J and Lenander-Lumikari M: Fungicidal effect of human lactoferrin against Candida albicans. FEMS Microbiol Lett 90: 223-228, 1992.
25. Naidu SS, Svensson U, Kishore AR and Naidu AS: Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother 37: 240-256, 1993.
26. Haversen L, Ohlsson GB, Hahn-Zoric M, Hanson LA and Mattsby-Baltzer I: Lactoferrin down-regulates the LPS-induced production in monocytic cells via NF-κB. Cell Immunol 220: 83-95, 2002. (Pubitemid 36349060)
27. Crouch SPM, Slater KJ and Fletcher J: Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80: 235-240, 1992.
28. Lima MF and Kierszenbaum F: Lactoferrin effects on phagocytic cell function increased uptake and killing of an intracellular parasite by murine macrophages and monocytes. J Immunol 134: 4176-4183, 1985. (Pubitemid 15029647)
29. Zimecki M, Mazurier J, Machnicki MZ, Machnicki M, Wieczorek Z, Montreuil J and Spik G: Immunostimulatory activity of lactotransferrin and maturation of CD4, CD8 murine thymocytes. Immunol Lett 30: 119-124, 1991.
30. Shau H, Kim A and Golub SH: Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J Leuk Biol 51: 343-349, 1992.
31. Cohen MS, Mao J, Rasmussen GT, Rasmussen GT, Serody JS and Britigan BE: Interaction of lactoferrin and lipopolysaccharide: effects on the antioxidant property of lactoferrin and the ability of lipopolysaccharide to prime human neutrophils for enhanced superoxide formation. J Infect Dis 166: 1375-1378, 1992.
32. Hasegawa A, Otsuki K, Sasaki Y, et al.: Preventive effect of recombinant human lactoferrin in a rabbit pre-term delivery model. Am J Obstet Gynecol: 1038-1043, 2005. (Pubitemid 40487776)